2016 Innovative Research Grant Recipients
Over a three-year period, each investigator will receive up to $750,000 for a total of $7.5 million awarded for SU2C Innovative Research Grants in 2016.
Watch the 2016 Innovative Research Grants recipients talk about their work and its potential impact on the treatment of people with cancer:
The 10 SU2C Innovative Research Grant recipients in 2016 are:
Targeting Cellular Plasticity in Individual Basal-type Breast Cancer Cells
John G. Albeck, PhD, is an assistant professor in the department of molecular and cellular biology at the University of California, Davis.
Uncovering How Rad51 Paralog Mutations Contribute to Cancer Predisposition
Kara A. Bernstein, PhD, is an assistant professor in the department of microbiology and molecular genetics at the University of Pittsburgh.
Phospholipid Messengers as Drivers of Dendritic Cell Dysfunction in Cancer
Juan R. Cubillos-Ruiz, PhD, is an assistant professor of microbiology and immunology in obstetrics and gynecology at Weill Cornell Medicine.
Metabolic Reprogramming Using Oncolytic Viruses to Improve Immunotherapy
Greg M. Delgoffe, PhD, is an assistant professor in the department of immunology at the University of Pittsburgh.
“Weak Links” in Cancer Proteostasis Networks as New Therapeutic Targets
Martin Kampmann, PhD, is an assistant professor in the department of biochemistry and biophysics at the University of California, San Francisco.
Algorithmically-driven Quantitative Combination Cancer Therapy Engineering
Dan A. Landau, MD, PhD, is an assistant professor of medicine in the division of hematology and medical oncology at Weill Cornell Medicine.
Deubiquitinating Enzymes as Novel Anticancer Targets
Li Ma, PhD, is an associate professor in the department of experimental radiation oncology and the division of radiation oncology at The University of Texas MD Anderson Cancer Center.
Imaging Cell-Level Heterogeneity in Solid Tumors for Personalized Treatment
Melissa Skala, PhD, is an investigator and professor of biomedical engineering at the Mordridge Institute for Research and University of Wisconsin, Madison.
(Morgridge Institute for Research, University of Wisconsin, Madison; Effective July 2016)
Defining the Metabolic Dependencies of Tumors
Matthew Vander Heiden, MD, PhD, is the Eisen and Chang career development professor at the Koch Institute for Integrative Cancer Research and the department of biology at the Massachusetts Institute of Technology.
Defining the Mechanistic Connections Between Injury, Regeneration, and Cancer
Hao Zhu, MD, is an assistant professor of pediatrics at University of Texas Southwestern Medical Center.
Updated: May 2016